Publication | Closed Access

Reduction of in vivo tumor growth by MMI-166, a selective matrix metalloproteinase inhibitor, through inhibition of tumor angiogenesis in squamous cell carcinoma cell lines of head and neck

Tumor BiologyAngiogenesisMedicineCancer GrowthPathologyHead And Neck CancerTumor TargetingCancer TreatmentOncologyCell BiologyVivo Tumor GrowthTumor MicroenvironmentCancer ResearchTumor Angiogenesis